Wednesday, September 17, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Mergers & Acquisitions

Intel Secures $3.3 Billion Deal in Strategic Restructuring Move

Robert Sasse by Robert Sasse
September 17, 2025
in Mergers & Acquisitions, Semiconductors, Tech & Software, Turnaround
0
Intel Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Intel has executed a significant transaction within its broader turnaround strategy, a move welcomed by investors. The semiconductor giant, which has faced considerable challenges, finalized the sale of a majority stake in its Altera unit for $3.3 billion. Concurrently, the company revised its operational cost forecast downward, signaling a renewed focus on financial discipline. The central question remains whether this strategic divestiture can truly catalyze a sustained recovery for the chipmaker.

A Pivotal Transaction for the Chipmaker

On September 12, Intel completed the sale of a 51% interest in its programmable chip division, Altera, to the private equity firm Silver Lake. This transaction stands in stark contrast to the unit’s original acquisition cost; Intel purchased Altera in 2015 for nearly $17 billion. The deal values the majority stake at a fraction of that initial investment, though Intel will retain a 49% minority shareholding.

The immediate financial impact is constructive. Intel has lowered its projected operating expenses for 2025 to $16.8 billion, down from a previous forecast of $17 billion. Furthermore, Altera will no longer be fully consolidated on Intel’s balance sheet from the closing date, providing a measure of financial relief.

Should investors sell immediately? Or is it worth buying Intel?

Leadership’s Radical Refocusing Strategy

This sale is a cornerstone of the sweeping restructuring plan led by CEO Lip-Bu Tan, who is guiding Intel through one of its most complex periods. The overarching strategy involves a sharpened focus on core growth areas, specifically its foundry services and AI chip segments, to better compete with industry leaders like TSMC.

Key Deal Metrics:
– Transaction Value: $3.3 billion for a 51% stake
– Altera H1 2025 Revenue: $816 million
– Altera Gross Margin: 55%
– Intel’s Retained Stake: 49%

Market Response and the Road Ahead

Investor reaction to the announcement was positive, with Intel’s stock advancing approximately one percent. However, the true test of this strategic shift is yet to come. The company must now demonstrate that its intensified focus on foundry operations and artificial intelligence technologies will yield tangible results. Upcoming quarterly earnings reports will provide the first clear look at Intel’s operational performance following the deconsolidation of Altera, offering a more precise picture of its core business strength.

Ad

Intel Stock: Buy or Sell?! New Intel Analysis from September 17 delivers the answer:

The latest Intel figures speak for themselves: Urgent action needed for Intel investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 17.

Intel: Buy or sell? Read more here...

Tags: Intel
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Global Water Stock
Earnings

Can Strategic Acquisitions Drive Growth for Global Water Resources?

September 17, 2025
Aura Biosciences Stock
Analysis

Aura Biosciences: Wall Street Sees 250% Upside Despite Prolonged Share Price Weakness

September 17, 2025
VanEck Video Gaming and eSports ETF Stock
ETF

VanEck’s Gaming ETF Maintains Exceptional Growth Trajectory

September 17, 2025
Next Post
Pepsi Stock

Activist Investor Elliott Takes $4 Billion Stake in PepsiCo, Demands Strategic Overhaul

Oracle Stock

Oracle Stock Surges on Potential TikTok Partnership Breakthrough

Salesforce Stock

Salesforce Faces Dual Pressures: Insider Selling and FBI Cyberattack Warning

Recommended

Simulations Plus Stock

A Perfect Storm Engulfs Simulations Plus

4 weeks ago
WW International Stock

WW International Shares Extend Decline Amid Sector Pressures

1 week ago
Can ex-cons work at Walmart

Ikena Oncologys Q4 Earnings Report A Closer Look at Financial Performance

2 years ago
ICF Stock

ICF Secures Major Contract to Advance Residential Energy Modernization

3 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir Realty Income Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Agios Shares Tumble as FDA Pushes Back Key Drug Decision

Delek US Shares: Diverging Signals from Analysts and Corporate Insiders

Aura Biosciences: Wall Street Sees 250% Upside Despite Prolonged Share Price Weakness

Lockheed Martin Investors Face Crosscurrents of Major Contract and Legal Challenge

VanEck’s Gaming ETF Maintains Exceptional Growth Trajectory

OFS Credit Faces Investor Scrutiny After Earnings Miss and Declining Asset Value

Trending

Generac Stock
Analysis

Generac Stock: A Temporary Pause in a Powerful Rally

by Andreas Sommer
September 17, 2025
0

Despite a minor pullback in its share price, Generac Holdings Inc. continues to demonstrate formidable fundamental strength,...

Nuvalent Stock

Nuvalent Stock Faces Critical Juncture Ahead of Key Catalysts

September 17, 2025
Global Water Stock

Can Strategic Acquisitions Drive Growth for Global Water Resources?

September 17, 2025
Agios Stock

Agios Shares Tumble as FDA Pushes Back Key Drug Decision

September 17, 2025
Delek US Stock

Delek US Shares: Diverging Signals from Analysts and Corporate Insiders

September 17, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Generac Stock: A Temporary Pause in a Powerful Rally September 17, 2025
  • Nuvalent Stock Faces Critical Juncture Ahead of Key Catalysts September 17, 2025
  • Can Strategic Acquisitions Drive Growth for Global Water Resources? September 17, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com